KR900006575B1 - 사독(蛇毒) 성장정지 펩티드, 및 그 수득 및 정제방법 - Google Patents

사독(蛇毒) 성장정지 펩티드, 및 그 수득 및 정제방법 Download PDF

Info

Publication number
KR900006575B1
KR900006575B1 KR1019860009886A KR860009886A KR900006575B1 KR 900006575 B1 KR900006575 B1 KR 900006575B1 KR 1019860009886 A KR1019860009886 A KR 1019860009886A KR 860009886 A KR860009886 A KR 860009886A KR 900006575 B1 KR900006575 B1 KR 900006575B1
Authority
KR
South Korea
Prior art keywords
amino acid
aliphatic
carbon atoms
polar
toxic peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019860009886A
Other languages
English (en)
Korean (ko)
Other versions
KR870005014A (ko
Inventor
마르크바르트 한스
제이. 토다로 조지
알. 트바르드찌크 다니엘
Original Assignee
온코겐, 어 리미티드 파트너쉽
브래들리 더블유. 시몬스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 온코겐, 어 리미티드 파트너쉽, 브래들리 더블유. 시몬스 filed Critical 온코겐, 어 리미티드 파트너쉽
Publication of KR870005014A publication Critical patent/KR870005014A/ko
Application granted granted Critical
Publication of KR900006575B1 publication Critical patent/KR900006575B1/ko
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds
    • Y10S530/856Snakes; venom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019860009886A 1985-11-22 1986-11-22 사독(蛇毒) 성장정지 펩티드, 및 그 수득 및 정제방법 Expired KR900006575B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/801,019 US4731439A (en) 1985-11-22 1985-11-22 Snake venom growth arresting peptide
US801019 1985-11-22
US801.019 1985-11-22

Publications (2)

Publication Number Publication Date
KR870005014A KR870005014A (ko) 1987-06-04
KR900006575B1 true KR900006575B1 (ko) 1990-09-13

Family

ID=25179974

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860009886A Expired KR900006575B1 (ko) 1985-11-22 1986-11-22 사독(蛇毒) 성장정지 펩티드, 및 그 수득 및 정제방법

Country Status (20)

Country Link
US (1) US4731439A (https=)
KR (1) KR900006575B1 (https=)
CN (1) CN86108593A (https=)
AU (3) AU6556386A (https=)
BE (1) BE905790A (https=)
CH (1) CH670451A5 (https=)
DE (1) DE3639796A1 (https=)
DK (1) DK560986A (https=)
ES (1) ES2002915A6 (https=)
FI (1) FI864715A7 (https=)
FR (1) FR2590576A1 (https=)
GB (1) GB2185023B (https=)
GR (1) GR862788B (https=)
IT (1) IT1207580B (https=)
LU (1) LU86683A1 (https=)
NL (1) NL8602939A (https=)
PT (1) PT83790B (https=)
SE (1) SE8604991L (https=)
YU (1) YU199586A (https=)
ZA (1) ZA868849B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5939890A (en) * 1989-06-07 1991-01-07 Genentech Inc. Platelet aggregation inhibitors and related molecules
WO1991001740A1 (en) * 1989-08-05 1991-02-21 Varánusz Gm Process for producing pharmacosmetics
US5232911A (en) * 1990-01-03 1993-08-03 Ventech Research Inc. Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
NZ253611A (en) * 1992-07-27 1996-09-25 Pfizer Polypeptide found in the venom of the agelenopsis spider and its use as a calcium channel blocker
DE4433890C2 (de) * 1994-09-22 1999-02-18 Deutsches Krebsforsch Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein
SG129211A1 (en) * 1997-11-06 2007-02-26 Univ Singapore Therapeutic molecules
BR0101088A (pt) * 2001-03-19 2003-03-18 Biolab Sanus Farmaceutica Ltda Processo de isolamento e purificação de peptìdeos inibidores das vasopeptidases, com especificidade para o sìtio carboxìlico da enzima conversora da angiotensina, secretados pelas glândulas do veneno de serpentes (bpps), particularmente bothrops jararaca, ou produzidos endogenamente (evasins) possuindo ação vasodilatadora e anti-hipertensiva; processo de determinação da sequência de amido-ácidos dos peptìdios inibidores secretados pela glândula de veneno de serpentes (bpps) ou endógenos (evasins); processo de determinação da sequência de aminoácidos dos bpps por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca. processo de determinação da sequência de aminoácidos dos evasins por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca, processo de amplificação do cdna a partir das bibliotecas de cdna de pâncreas e/ou cérebro de serpentes, especificamente bothrops jararaca; processo de sìntese em fase sólida de peptìdeos inibidores das vasopeptidases com ação vasodilatadora e anti-hipertensiva, peptìdeos inibidores das vasopeptidases com ação anti-hipertensiva; utilização dos peptìdeos inibidores das vaso peptidases com ação vasodilatadora e anti-hipertensiva na obtenção de composições farmacêuticas; processo de determinação da atividade inibitória sobre as vasopeptidases e de atividade biológica sobre músculo liso, sistema cardiovascular e microcirculatório.
BRPI0501037B8 (pt) * 2005-03-18 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo uso de crotamina e composição
US20060234934A1 (en) * 2005-04-15 2006-10-19 Kilmon Joseph A Composition and Method for Selective Cytostasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5836308B2 (ja) * 1977-02-10 1983-08-08 大塚製薬株式会社 抗体の製造方法
US4220722A (en) * 1978-02-10 1980-09-02 Syva Company Method for conjugating to polyamino compounds employing haloacyl groups and compositions prepared thereby
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
US4500637A (en) * 1982-07-19 1985-02-19 The United States Of America As Represented By The Department Of Health And Human Services Prevention of graft versus host disease following bone marrow transplantation

Also Published As

Publication number Publication date
US4731439A (en) 1988-03-15
GB8627710D0 (en) 1986-12-17
DK560986D0 (da) 1986-11-21
GB2185023B (en) 1990-08-29
PT83790A (en) 1986-12-01
DK560986A (da) 1987-05-23
IT1207580B (it) 1989-05-25
FR2590576A1 (fr) 1987-05-29
FI864715A7 (fi) 1987-05-23
CN86108593A (zh) 1987-09-30
ES2002915A6 (es) 1988-10-01
KR870005014A (ko) 1987-06-04
DE3639796A1 (de) 1987-07-09
ZA868849B (en) 1987-07-29
PT83790B (pt) 1989-09-14
AU6667590A (en) 1991-03-28
NL8602939A (nl) 1987-06-16
GB2185023A (en) 1987-07-08
SE8604991L (sv) 1987-05-23
AU6560986A (en) 1987-05-28
FI864715A0 (fi) 1986-11-19
CH670451A5 (https=) 1989-06-15
GR862788B (en) 1987-03-26
AU6556386A (en) 1987-05-28
SE8604991D0 (sv) 1986-11-21
BE905790A (fr) 1987-05-19
IT8622425A0 (it) 1986-11-21
LU86683A1 (fr) 1987-06-26
YU199586A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
Tatemoto et al. Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin
Gregory et al. The primary structure of human urogastrone
Meki et al. A bradykinin-potentiating peptide (peptide K12) isolated from the venom of Egyptian scorpion Buthus occitanus
Selsted et al. Determination of the disulfide array in the human defensin HNP-2: a covalently cyclized peptide
Nakaya et al. Amino acid sequence and disulfide bridges of an antifungal protein isolated from Aspergillus giganteus
Babin et al. Amino acid sequences of neurotoxic protein variants from the venom of Centruroides sculpturatus Ewing
KR900006575B1 (ko) 사독(蛇毒) 성장정지 펩티드, 및 그 수득 및 정제방법
KR100287461B1 (ko) 항생물질 크립트딘 펩티드 및 그들의 사용법(antibiotic cryptdin peptides and methods of their use)
Carlsson Snake venom toxins the primary structure of protein S4C11: A neurotoxin homologue from the venom of forest cobra (Naja melanoleuca)
EP0205555B1 (en) Serine protease inhibitors and methods for isolation of same
CA2223737A1 (en) Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
GB1572889A (en) Polypeptides
US4774318A (en) Snake venom growth arresting peptide
Adermann et al. Isolation, characterization and synthesis of a novel pardaxin isoform
US6153738A (en) Contryphan peptides
塩見一雄 et al. Isolation and properties of four serine protease inhibitors in the sea anemone Actinia equina.
US4559324A (en) Polypeptide-diesters, their production and use
Kmiecik et al. Primary structure of histone H2A from nucleated erythrocyte of the marine worm Sipunculus nudus Presence of two forms of H2A in the sipunculid chromatin
AU719632B2 (en) Contryphan peptides
Ohta et al. Localization of the five disulfide bridges in toxin B from the venom of the Indian cobra (Naja naja)
Samejima et al. Amino acid sequence of two neurotoxins from the venom of the Egyptian black snake (Walterinnesia aegyptia)
Diaz et al. A large-scale synthesis of somatostatin for clinical use by a novel alternating solution/solid-phase procedure
JPH01131196A (ja) 蛇毒の生長阻止性ペプチド
Yang Chemistry and biochemistry of snake venom neurotoxins
JP3776968B2 (ja) ペプチド性サソリ毒素

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19930914

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19930914

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000